Detailed information of GRHL2

  1. Home
  2. TF > GRHL2

Dataset summary

TF Name: GRHL2 Species: Mus musculus
Cell-type/Tissue: epiblast cells Condition/Source: Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype
JASPAR ID: MA1105.2 Collections: Permissive Robust
References: GEO GSE92745 GSM2436762 GTRD EXP052007 PUBMED 30017589

External links

Models for profile: MA1105.2

Download TFBSs (mm10)

Download TFBSs in BED and FASTA format

Download trained model

Download trained prediction models

Visualize TFBSs in UCSC

Send TFBSs BED file to UCSC genome browser

Summary plots

Statistical details

Model Peak caller Model ID Enrichment Zone TFBSs Score threshold Centrality p-value (log10)
DAMO MACS MA1105.2 63.5 2949 83.6 -25.7867313142864

22 datasets found for the same TF (GRHL2) in other cell-types/tissues

TF Name Cell-line Condition/Source Collections Species Identifiers JASPAR ID
GRHL2 MCF7 (Invasive ductal breast carcinoma) No treatment Permissive Robust Homo sapiens GSE81714 ... MA1105.2
GRHL2 MCF7 (Invasive ductal breast carcinoma) control Permissive Robust Homo sapiens GSE109820 ... MA1105.2
GRHL2 MCF7 (Invasive ductal breast carcinoma) control Permissive Robust Homo sapiens GSE109820 ... MA1105.2
GRHL2 MCF7 (Invasive ductal breast carcinoma) control Permissive Robust Homo sapiens GSE109820 ... MA1105.2
GRHL2 MCF7 (Invasive ductal breast carcinoma) 100nm E2 (45 min) Permissive Robust Homo sapiens GSE109820 ... MA1105.2
GRHL2 MCF7 (Invasive ductal breast carcinoma) 100nm E2 (45 min) Permissive Robust Homo sapiens GSE109820 ... MA1105.2
GRHL2 MCF7 (Invasive ductal breast carcinoma) 100nm E2 (45 min) Permissive Robust Homo sapiens GSE109820 ... MA1105.2
GRHL2 MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) Treatment: 45 min ethanol Permissive Robust Homo sapiens GSE113092 ... MA1105.2
GRHL2 MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) Treatment: 45 min ethanol Permissive Robust Homo sapiens GSE113092 ... MA1105.2
GRHL2 MCF7 TamR (invasive ductal breast carcinoma Tamoxifen resistant) Treatment: 45 min ethanol Permissive Robust Homo sapiens GSE113092 ... MA1105.2
GRHL2 MCF7 WS8 cells Treatment: 45 min ethanol Permissive Robust Homo sapiens GSE113092 ... MA1105.2
GRHL2 MCF7 WS8 cells Treatment: 45 min ethanol Permissive Robust Homo sapiens GSE113092 ... MA1105.2
GRHL2 MCF7 WS8 cells Treatment: 45 min ethanol Permissive Robust Homo sapiens GSE113092 ... MA1105.2
GRHL2 epiblast cells Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: wildtype Permissive Robust Mus musculus GSE92745 ... MA1105.2
GRHL2 epiblast cells Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: GRHL2 knockout Permissive Robust Mus musculus GSE92745 ... MA1105.2
GRHL2 epiblast cells Origin: cell line V6.5 ESCs Treatment: grown in 2i, day 3 (GSKi and MEKi), doxycycline was added at 0.5ug/ml for 24hrs Genotype: GRHL2 knockout Permissive Robust Mus musculus GSE92745 ... MA1105.2
GRHL2 placenta Permissive Robust Mus musculus GSE65962 ... MA1105.2
GRHL2 LNCaP (prostate carcinoma) Permissive Robust Homo sapiens GSE80256 ... MA1105.2
GRHL2 Permissive Robust Homo sapiens GSE46194 MA1105.2
GRHL2 OVCA429 (ovarian cystadenocarcinoma) Permissive Robust Homo sapiens GSE71018 MA1105.2
GRHL2 OVCAR3 (high grade ovarian serous adenocarcinoma) Permissive Robust Homo sapiens GSE71018 MA1105.2
GRHL2 PEO1 (ovarian cystadenocarcinoma) Permissive Robust Homo sapiens GSE71018 MA1105.2